Diagnostik in der psychodynamischen Gruppenpsychotherapie
In: Gruppenpsychotherapie und Gruppendynamik: Beiträge zur Sozialpsychologie und therapeutischen Praxis, Band 59, Heft 1, S. 29-45
ISSN: 2196-7989
7 Ergebnisse
Sortierung:
In: Gruppenpsychotherapie und Gruppendynamik: Beiträge zur Sozialpsychologie und therapeutischen Praxis, Band 59, Heft 1, S. 29-45
ISSN: 2196-7989
In: Gruppenpsychotherapie und Gruppendynamik: Beiträge zur Sozialpsychologie und therapeutischen Praxis, Band 57, Heft 3, S. 207-223
ISSN: 2196-7989
In: Gruppenpsychotherapie und Gruppendynamik: Beiträge zur Sozialpsychologie und therapeutischen Praxis, Band 59, Heft 4, S. 287-307
ISSN: 2196-7989
In: Gruppenpsychotherapie und Gruppendynamik: Beiträge zur Sozialpsychologie und therapeutischen Praxis, Band 55, Heft 4, S. 352-369
ISSN: 2196-7989
Altres ajuts: The study received grant 08-MNP-007 from the French government Agence Nationale de la Recherche and grant AOM-07-118 (Influence of Cannabis Psychopathological Outcome in At-risk Mental State [ICAAR study]) from the French Health Ministry Programme Hospitalier de Recherche Clinique. The Sainte-Anne Hospital Center promoted the study. Dr Kempton was supported by a Medical Research Council Fellowship grant MR/J008915/1. Dr Pantelis was supported by Australia's National Health and Medical Research Council Senior Principal Research Fellowship (ID: 628386 & 1105825) and by grant R246-2016-3237 from the Lundbeck Foundation. Dr Modinos was supported by a Sir Henry Dale Fellowship #202397/Z/16/Z, jointly funded by The Wellcome Trust and the Royal Society. ; This case-control study analyzes emotion recognition and neuroimaging data as well as clinical and functional outcomes for individuals at risk for transition to psychosis and those without psychiatric or neurological disorders. Is altered emotion recognition associated with adverse clinical and functional outcomes in people at clinical high risk for psychosis? In this case-control study of 213 individuals at clinical high risk for psychosis and 52 healthy participants, abnormalities in the recognition of negative emotion at baseline were associated with neuroanatomical alterations in the medial prefrontal cortex and hippocampus and with a low level of functioning at a 12-month follow-up. This study found that, in people with high risk for developing psychosis, functional outcomes are associated with the degree to which their emotion processing is altered. The development of adverse clinical outcomes in patients with psychosis has been associated with behavioral and neuroanatomical deficits related to emotion processing. However, the association between alterations in brain regions subserving emotion processing and clinical outcomes remains unclear. To examine the association between alterations in emotion processing and regional gray matter volumes ...
BASE
PSYSCAN Consortium. ; In the last 2 decades, several neuroimaging studies investigated brain abnormalities associated with the early stages of psychosis in the hope that these could aid the prediction of onset and clinical outcome. Despite advancements in the field, neuroimaging has yet to deliver. This is in part explained by the use of univariate analytical techniques, small samples and lack of statistical power, lack of external validation of potential biomarkers, and lack of integration of nonimaging measures (eg, genetic, clinical, cognitive data). PSYSCAN is an international, longitudinal, multicenter study on the early stages of psychosis which uses machine learning techniques to analyze imaging, clinical, cognitive, and biological data with the aim of facilitating the prediction of psychosis onset and outcome. In this article, we provide an overview of the PSYSCAN protocol and we discuss benefits and methodological challenges of large multicenter studies that employ neuroimaging measures. ; The PSYSCAN Project is supported by grant agreement no. 603196 under the European Union's Seventh Framework Programme. ; Peer reviewed
BASE
PSYSCAN Consortium. ; In the last 2 decades, several neuroimaging studies investigated brain abnormalities associated with the early stages of psychosis in the hope that these could aid the prediction of onset and clinical outcome. Despite advancements in the field, neuroimaging has yet to deliver. This is in part explained by the use of univariate analytical techniques, small samples and lack of statistical power, lack of external validation of potential biomarkers, and lack of integration of nonimaging measures (eg, genetic, clinical, cognitive data). PSYSCAN is an international, longitudinal, multicenter study on the early stages of psychosis which uses machine learning techniques to analyze imaging, clinical, cognitive, and biological data with the aim of facilitating the prediction of psychosis onset and outcome. In this article, we provide an overview of the PSYSCAN protocol and we discuss benefits and methodological challenges of large multicenter studies that employ neuroimaging measures. ; The PSYSCAN Project is supported by grant agreement no. 603196 under the European Union's Seventh Framework Programme.
BASE